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Abstract:  
              This study proposes an efficient neural network with convolutional layers to classify 
significantly class-imbalanced clinical data. The data are curated from the National Health and 
Nutritional Examination Survey (NHANES) with the goal of predicting the occurrence of 
Coronary Heart Disease (CHD). While the majority of the existing machine learning models that 
have been used on this class of data are vulnerable to class imbalance even after the adjustment of 
class-specific weights, our simple two-layer CNN exhibits resilience to the imbalance with fair 
harmony in class-specific performance. In order to obtain significant improvement in classification 
accuracy under supervised learning settings, it is a common practice to train a neural network 
architecture with a massive data and thereafter, test the resulting network on a comparatively 
smaller amount of data. However, given a highly imbalanced dataset, it is often challenging to 
achieve a high class 1 (true CHD prediction rate) accuracy as the testing data size increases. We 
adopt a two-step approach: first, we employ least absolute shrinkage and selection operator 
(LASSO) based feature weight assessment followed by majority-voting based identification of 
important features. Next, the important features are homogenized by using a fully connected layer, 
a crucial step before passing the output of the layer to successive convolutional stages. We also 
propose a training routine per epoch, akin to a simulated annealing process, to boost the 
classification accuracy.    
Despite a 35:1 (Non-CHD:CHD) ratio in the NHANES dataset, the investigation confirms that our 
proposed CNN architecture has the classification power of 77% to correctly classify the presence 
of CHD and 81.8% the absence of CHD cases on a testing data, which is 85.70% of the total 
dataset. This result signifies that the proposed architecture can be generalized to other studies in 
healthcare with a similar order of features and imbalances. While the recall values obtained from 
other machine learning methods such as SVM and random forest are comparable to that of our 
proposed CNN model, our model predicts the negative (Non-CHD) cases with higher accuracy. 
The balanced accuracy of our model (79.5%) is also better than individual accuracies of SVM or 
random forest classifiers. The CNN classifier results in high specificity and test accuracy along 
with high values of recall and area under the curve (AUC). 
Keywords: Coronary heart disease, Machine learning, LASSO regression, Convolutional neural 
network, Artificial Intelligence, NHANES 
1. Introduction 
           Heart disease is a leading cause of death today, with coronary heart disease (CHD) being 
the most common form of cardiovascular disease that accounts for approximately 13% of deaths 
in the US (Benjamin, 2019). Timely diagnosis of heart disease is crucial in reducing health risk 
and preventing cardiac arrests. An American Heart Association study projects an almost 100% 
increase in CHD treatment by 2030 (Benjamin, 2019). Major risk factors such as smoking, 
hypertension, hyper cholesterol and diabetes have been studied in connection to CHD (Kannel, et 
al., 1971; Stamler, et al., 1993; Vasan, et al., 2001; Kannel, 1996; Burke et al., 1997; Celermajer 
et al., 1993; Chobanian et al., 2003; Haskell et al., 1994; Zeiher et al., 1993; Ahmed et al., 2017). 
Ahmed. et al. (2017) show that Body Mass Index (BMI) and systolic blood pressure are the two 
most critical factors affecting hypertension. Fava. et al. (2013) conclude significant association 
between age, sex, BMI and heart rate with hypertension. Studies in general population indicate 
that high level of creatinine in blood can increase the risk of CHD (Irie et al., 2006; Wannamethee, 
Shaper & Perry 1997). Additionally, blood cholesterol and glycohaemoglobin levels are found to 
be persistently and significantly high in patients with CHD (Burchfiel, 1997; Meigs et al., 1997). 
Several researchers have used statistical and machine learning models on echocardiography 
images (Nakanishi et. al., 2018; Madani et. al., 2018) and electrocardiography signals (Jin, 2009; 
Shen et. al., 2016) to predict clinically significant parameters related to CHD in patients, such as 
heart rate and axis deviation. Boosted algorithms such as gradient boost and logit boost have been 
used in literature to predict FFR and cardiovascular events (Weng et. al, 2017; Goldstein, 2017). 
Frizzell et al. and Mortazavi et al. built prediction models to determine the presence of 
cardiovascular disease using the 30-day readmission electronic data for patients with heart failure. 
The C-statistic of the models reported varied from 0.533 to 0.628, showing an improvement with 
the machine learning approach over traditional statistical methods.  
Numerous risk factor variables often make the prediction of CHD difficult, which in turn, increases 
the cost of diagnosis and treatment. In order to resolve the complexities and cost of diagnosis, 
advanced machine learning models are being widely used by researchers to predict CHD from 
clinical data of patients. Kurt et al. (2008) compared prediction performances of a number of 
machine learning models including the multilayer perceptron (MLP) and radial basis function 
(RBF) to predict the presence of CHD in 1245 subjects (Kurt et al., 2008). The MLP was found to 
be the most efficient method, yielding an area under the receiver operating characteristic (ROC) 
curve of 0.78.  Shilaskar and Ghatol (2013) proposed a hybrid forward selection technique wherein 
they were able to select smaller subsets and increase the accuracy of the presence of cardiovascular 
disease with reduced number of attributes. Several other groups have reported techniques, such as 
artificial neural network (ANN), fuzzy logic (FL) and deep learning (DL) methods to improve 
heart disease diagnosis (Uyar, 2017; Venkatesh, 2017). Nonetheless, in most of the previous 
studies, the patient cohort was limited to a few thousands with limited risk factors.  
We propose an efficient neural network with convolutional layers using the National Health and 
Nutritional Examination Survey (NHANES) dataset to predict the occurrence of CHD. A complete 
set of clinical, laboratory and examination data are used in the analysis along with a feature 
selection technique by LASSO regression. Data preprocessing is performed using LASSO 
followed by a feature voting and elimination technique. The performance of the network is 
compared to several existing traditional ML models in conjunction with the identification of a set 
of important features for CHD. Our architecture is simple in design, elegant in concept, 
sophisticated in training schedule, effective in outcome with far-reaching applicability in problems 
with unbalanced datasets. Our research contributes to the existing studies mainly in three ways: 1) 
our model uses a variable elimination technique using LASSO and feature voting as preprocessing 
steps; 2) then we leverage a shallow neural network with convolutional layers, which improves 
CHD prediction rates compared to existing models with comparable subjects. The ‘shallowness’ 
is dictated by the scarcity of class-specific data to prevent overfitting of the network during 
training; 3) in conjunction with the architecture, we propose a simulated annealing-like training 
schedule that is shown to minimize the generalization error between train and test losses.  
The rest of the paper is organized as follows: Section 2 explains data preparation and the 
preprocessing techniques. In section 3, we illustrate the convolutional neural network architecture 
with details on the training and testing methodology. In section 4 we demonstrate the results 
obtained from our model with performance evaluation metrics and compare it with existing 
models. Section 5 is the conclusion and discussion section. Here, several extensions to the research 
are proposed. 
 
2. Data Preprocessing 
              Our study uses the National Health and Nutrition Examination Survey (NHANES) data 
from 1999-2000 to 2015-2016. The dataset is compiled by combining the demographic, 
examination, laboratory and questionnaire data of 37,079 (CHD – 1300, Non-CHD – 35,779) 
individuals as shown in Figure 1. Demographic variables include age and gender of the survey 
participants at the time of screening. Participant weight, height, blood pressure and body mass 
index (BMI) from the examination data are also considered as a set of risk factor variables to study 
their effect on cardiovascular diseases. NHANES collects laboratory and survey data from  
 
Figure 1. Data compilation from National Health and Nutritional Survey (NHANES). The data is acquired from 1999 
to 2016 in three categories – Demography, Examination and Laboratory. Based on the nature of the factors that are 
considered, the dataset contains both the quantitative and the qualitative variables. 
 
 
TABLE I: Description of the risk factor independent variables and the dependent variable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
participants once in every two years depending on their age and gender. In addition, based on the 
already existing validated experimental research, a comprehensive list of risk factor variables is 
selected from the laboratory tests conducted. Questionnaire data comprises of questions asked at 
home by interviewers using a Computer-Assisted Personal Interview (CAPI) system as mentioned 
in the NHANES website (NHANES, 2015). A total of 5 dichotomous predictor categorical 
variables are selected from the questionnaire data which have been shown to affect CHD 
(references, required). In all, 30 continuous and 6 categorical independent variables are used to 
predict the likelihood of coronary heart disease.  For this study, coronary heart disease (CHD) is 
used as the dichotomous dependent variable. Awareness of CHD is defined as “yes” response to 
the question “Have you been ever told you had coronary heart disease?” Table I shows the 
categorical independent and dependent variables in the dataset considered for model development. 
Variable Name Description Code Meaning 
Gender Gender of the participant 1 
2 
Male 
Female 
Vigorous Activity 
12 years and 
above 
Vigorous activity in last 
one week or 30 days 
1 
2 
3 
Yes 
No 
Unable to do activity 
Moderate Activity 
12 years and 
above 
Moderate activity in last 
one week or 30 days 
1 
2 
3 
Yes 
No 
Unable to do activity 
Diabetes 
1 yr and above 
Doctor told that the 
participant has diabetes 
1 
2 
3 
Yes 
No 
Borderline 
Blood Relative 
Diabetes 
20 yrs and above 
Biological blood 
relatives ever told that 
they have diabetes 
1 
2 
Yes 
No 
 
Blood Relative 
Stroke 
20 yrs and above 
Biological blood 
relatives ever told that 
they have hypertension 
or stroke before the age 
of 50 
1 
2 
 
Yes 
No 
 
Coronary Heart 
Disease 
20 yrs and above 
Ever told that the 
participant had coronary 
heart disease 
1 
2 
Yes 
No 
The exhaustive list of variables is: gender, age, annual-family-income, ratio-family-income-
poverty, 60sec pulse rate, systolic, diastolic, weight, height, body mass index, white blood cells, 
lymphocyte, monocyte, eosinophils, basophils, red blood cells, hemoglobin, mean cell volume, 
mean concentration of hemoglobin, platelet count, mean volume of platelets, neutrophils, 
hematocrit, red blood cell width, albumin, alkaline phosphatase (ALP), aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), cholesterol, creatinine, glucose, gamma-glutamyl 
transferase (GGT), cholesterol, creatinine, glucose, iron, iron, lactate dehydrogenase (LDH), 
phosphorus, bilirubin, protein, uric acid, triglycerides, total cholesterol, high-density lipoprotein 
(HDL), glycohemoglobin, vigorous-work, moderate-work, health-Insurance, diabetes, blood 
related diabetes, and blood related stroke. However, in this list of variables, there are a couple of 
linearly dependent variables in terms of their nature of acquisition or quantification and some 
uncorrelated variables (annual family income, height, ratio of family income-poverty, 60 sec pulse 
rate, health insurance, lymphocyte, monocyte, eosinophils, total cholesterol, mean cell volume, 
mean concentration of hemoglobin, hematocrit, segmented neutrophils). We do not consider these 
variables for subsequent processing and analysis.  
 
3. Proposed Architecture 
3.1 LASSO Shrinkage and Majority Voting 
            LASSO or least absolute shrinkage and selection operator is a regression technique for 
variable selection and regularization to enhance the prediction accuracy and interpretability of the 
statistical model it produces. In LASSO, data values are shrunk toward a central point, and this 
algorithm helps in variable selection and parameter elimination. This type of regression is well-
suited for models with high multicollinearity. LASSO regression adds a penalty equal to the 
absolute value of the magnitude of coefficients, and some coefficients can become zero and are 
eventually eliminated from the model. This results in variable elimination and hence models with 
fewer coefficients. LASSO solutions are quadratic problems and the goal of the algorithm is to 
minimize: 
                                                     ∑ (𝑦𝑖 − ∑ 𝑥𝑖𝑗𝛾𝑗
𝑗
)
2
+ 𝜆 ∑ |𝛾𝑗|
𝑝
𝑗=1
                                                      (1)
𝑛
𝑖=1
 
 
which is the same as minimizing the sum of squares with constraint  ∑ |𝛾𝑗| ≤ 𝑠. Some of the 𝛾 
values are shrunk to exactly zero, resulting in a regression model that’s easier to interpret. A tuning 
parameter, λ which is the amount of shrinkage, controls the strength of the regularization penalty. 
When λ = 0, no parameters are eliminated. The estimate is equal to the one found with linear 
regression. As λ increases, more coefficients are set to zero and eliminated. As λ increases, bias 
increases and as λ decreases, variance increases. The model intercept is usually left unchanged. 
The 𝛾 value for a variable (factor) can be interpreted as the importance of the variable in terms of 
how the it contributes to the underlying variation in the data. The variable with a zero 𝛾 is 
considered unimportant. It is to note that LASSO shows misleading results in case of data 
imbalance, which may prompt incorrect selection of important variables if we perform LASSO on 
the entire dataset.  
In order to mitigate the effect of imbalance, we adopt a strategy to randomly subsample the dataset 
and iterate LASSO multiple times. Majority voting is performed on the set of  𝛾 values to identify 
the variable that are nonzero in major number of iterations. Let us assume, that LASSO is 
performed N times on N randomly subsampled dataset, where each instance has equal number of 
examples in case of CHD and no-CHD. With 45 variables at hand, we obtain 𝛾𝑖 =
 [𝛾𝑖,1 𝛾𝑖,2 … … 𝛾𝑖,45 ] at 𝑖
𝑡ℎ instance of LASSO. For any variable c, we count the number of 
instances in which the variable is non-zero, and with a manually set threshold, we decide the 
selection of that variable for further analysis. Mathematically, 
 
𝜒(𝛾) =  {
1     𝑖𝑓 𝛾 ≠ 0
0 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
 
    
                                        [𝜒(𝛾1,𝑐) 𝜒(𝛾2,𝑐) … …  𝜒(𝛾𝑁,𝑐)]𝟏 ≥  
𝑵
𝜶
 ⟹ 𝐜 is selected                            (2) 
 
3.2. Convolutional Neural Network (CNN) 
               The challenge of predicting the existence of CHD in patients refers to the task of binary 
classification. Under certain constraints, neural network (LeCun, 2015; Goodfellow, 2016) has 
been proven to be an effective parametric classifier under supervised settings. Recently, with the 
explosion of structured data, deep neural networks incorporating a large number of application-
specific hidden layers, have demonstrated significant improvement in several areas including 
speech processing, applications involving image processing, and time series prediction (LeCun, 
1995). There is a vast body of deep learning architectures that are fine-tuned and rigorously trained 
using big datasets. An artificial neural network (Iandola, 2016; Krizhevsky, 2012; Szegedy, 2017; 
He, 2016) successively transforms the input data over sequential hidden layers and estimates the 
error at the output layer. The error is back- propagated to iteratively update the layer weights using 
gradient descent algorithm. Rigorous experimentations and analyses have proposed several 
improvements in the gradient descent algorithm, the nonlinearity of layers, overfitting reduction, 
training schedule, hidden layer visualization and other modifications. Despite resounding success 
in applications, the working principle of deep neural networks is still poorly understood. It is also 
found in practice that a deep neural network is extremely susceptible to be attacked by adversarial 
examples. In addition, owing to millions of parameters in a typical deep architecture, the trained 
network may be overfitted, especially in cases where there is scarcity of examples.  
Among various algorithms that attempted to overcome this problem, data augmentation 
(Krizhevsky, 2012; Radford, 2015) is a widely used technique that artificially generates examples 
to populate small datasets. However, such a procedure is biologically implausible in most clinical 
datasets. For example, augmented measurements of a CHD phenotype, such as platelet count, 
might not correspond to possible readings of a subject. It is because the underlying principles of 
the statistical generation and the biological sources of platelet count readings may be 
fundamentally different. Poor training due to small or imbalanced datasets and susceptibility to 
adversarial examples lead to poor and unreasonable classification. Unlike many computer vision 
tasks, such as semantic labeling, chat-bot configuration, and hallucinogenic image synthesis 
(Mordvintsev, 2015), erroneous prediction in medical research is accompanied by a significant 
penalty.  
For example, faulty prediction of a subject having chronic CHD may leave the subject untreated 
or misdirect the possible therapeutic medication. Therefore, one of the prime objectives of this 
paper is to improve classification accuracy, i.e. the prediction accuracy of the subjects with and 
without the presence of CHD. There are several other relevant concerns related to misclassification 
in medical research (Marcus, 2018). To overcome these limitations and driven by the success of 
deep networks, we propose a shallow convolutional neural network, where the convolution layers 
are ‘sandwiched’ between two fully connected layers as shown in Fig. 2.  
 
3.2. CNN Architecture 
             The architecture is a sequential one-input-one-output feedforward network. For simplicity, 
we assume the class of subjects with presence of CHD as class ‘1’ and the subjects with absence 
of CHD as class ‘0’. As mentioned in the previous section, the number of active phenotypes of 
CHD obtained from majority voting is 50. Let the number of training examples be N, which  
Fig 2. Proposed convolutional neural network architecture. The ‘Input’ is a 1D numerical array 
corresponding to all the factors/variables from LASSO-Majority Voting preprocessing stage. The ‘Dense’ 
layer, immediately after the ‘Input’, combines all the factors and each neuron (computing node) at the 
output of ‘Dense’ layer is a weighted combination of all the variables, indicating a homogeneous mix of 
different variable types. The next two convolution layers seek representation of the input variables via the 
‘Dense’ layer. The next two ‘Dense’ layers are followed by the ‘Softmax’ layer. The last two ‘Dense’ layers 
(before the ‘Softmax’ layer) can be retrained for transfer learning in case new data is obtained. The 
associated training parameters, such as dropout probability, number of neurons, activation function (we 
used ReLU), pooling types, and convolution filter parameters are shown in the above figure. Owing to the 
large number of parameters that can lead to overfitting of training data points, we propose a training 
schedule in section 3.2.1. 
 
indicates that the input layer in Fig. 2 has dimension of ℛ𝑁 𝑋 50. The dense or fully connected 
layers, consisting of 64 neurons collectively act as a linear combiner of the 50 variables and bias, 
which effectively homogenizes different variable types before nonlinear transformation. The 
nonlinear transformation is carried out by rectified linear unit (ReLU). Dropout with 20% 
probability is performed to reduce overfitting. Following the fully-connected layer, there is a 
cascade of convolution layers. In the first convolution layer, there are two filters of kernel width 3 
and stride 1. The layer is not provided with external zero-padding. In the pooling layer, we 
rigorously experiment with different pooling strategies and find average pooling working 
marginally better than max pooling under all constraints. The first convolution layer converts the 
output of fully connected block ∈  ℛ𝑁 𝑋 64to a tensor of dimension ℛ𝑁 𝑋 64 𝑋 1. The tensor is then 
subjected to batch normalization, nonlinear transformation and average pooling with an output 
tensor of dimension ℛ𝑁 𝑋 31 𝑋 2.  
The filters in the last no-zero-padded convolution layers are taken with kernel 5 and stride 1, 
delivering an output tensor of ℛ𝑁𝑋13𝑋4 to the next dense layer after the average pooling layers. 
The categorical output is observed at the end of the softmax layer, where we set the loss function 
as the categorical cross-entropy loss. The bias in each layer is initialized with random numbers 
drawn from a truncated normal distribution with variance 
1
√𝑛
, where 𝑛 is the number of ‘fan-in’ 
connections to the layer. We use Adam optimizer with learning rate 0.005, 𝛽1 = 0.9, 𝛽2 = 0.999 
and zero decay. Our proposed architecture consists of 32,642 trainable and 1,164 non-trainable 
parameters. We experiment with several hyperparameters that are associated with our model to 
obtain consistent class-wise accuracy. We provide results by varying subsampling of input data, 
epochs, class-weights, the number of neurons in each dense layer except the last one, and the 
number of filters in each convolution layer during training.  
 
3.2.1. Training schedule 
            During training, the class weight ratio, which is adjusted as a penalty factor due to class 
imbalance, is defined as the ratio of CHD and Non-CHD dataset. For example, a class weight ratio 
of 10:1 indicates that any misclassification of a CHD training sample will be penalized 10 times 
more than a misclassified Non-CHD sample during the error calculation at the output prior to 
backpropagation after each epoch. Although, we use dropout layers in our CNN model, we also 
use this training schedule in order to further reduce possible overfitting. The intuition is to initially 
train the model with 1:Ν weight ratio for sufficiently large number of epochs and then, gradually 
increase the weight ratio with a steady decline in the number of epochs. Let the actual class weight 
ratio is 𝜌0: 1, which we take as a factor 𝜌0.    
  
 
Fitting our CNN model, M, by varying the number of epochs (𝜔) and weight ratio (𝜌) 
1. Initialize 𝜌 = Ν, 𝜔 (large number, we set as Ν), M, end_iter (5-10 depending on the instance), i=1 
2. While  𝜌 ≤  𝜌0 
M.fit (Data, 𝜔, 𝜌) 
                𝜌 ←  𝑓𝑙𝑜𝑜𝑟(
𝜌
2
) 
 𝜔 ← 𝑓𝑙𝑜𝑜𝑟 (
𝜔
2
) 
3.   While (𝑖 ≤ 𝑒𝑛𝑑_𝑖𝑡𝑒𝑟) and 𝑇𝑟𝑎𝑖𝑛𝑙𝑜𝑠𝑠(𝑖)  ≤  𝑇𝑟𝑎𝑖𝑛𝑙𝑜𝑠𝑠(𝑖 − 1) 
M.fit (Data, 𝑖, 𝜌0)  
3.3 Competitive Approaches 
               Machine learning classification methods have shown to potentially improve prediction 
outcomes in coronary heart disease. Such classification methods include logistic regression, 
support vector machines, random forests, boosting methods and multilayer perceptron (Goldstein, 
2017). Logistic regression models the prediction of a binomial outcome with one or more 
explanatory variables, using a standard logistic function which measures the relationship between 
the categorical dependent variable and one or more independent variables by estimating the 
probabilities. The logistic function is given by, 𝑓(𝑥) =
1
1+𝑒−𝑥
 which in common practice is known 
as the sigmoid curve. Support vector machine (SVM) is a binary classification algorithm which 
generates a (N-1) dimensional hyperplane to separate points into two distinct classes in an N 
dimensional plane. The classification hyperplane is constructed in a high dimensional space that 
represents the largest separation, or margin, between the two classes.  
Random forests are an ensemble learning algorithm where decision trees that grow deep are 
averaged and trained on different parts of the training set to reduce variance and avoid overfitting. 
Random forests algorithm employs bagging or bootstrap aggregating and at each split a random 
subset of features are selected. Bagging is a parallel ensemble because each model is built 
independently. Boosting on the other hand is a sequential ensemble where each model is built 
based on correcting the misclassifications of the previous model. In boosting methods, the weights 
are initialized on training samples and for n iterations, a classifier is trained using a single feature 
and training error evaluated. Then the classifier with the lowest error is chosen and the weights are 
updated accordingly; the final classifier is formed as a linear combination of n classifiers. A boost 
classifier is in the form, 𝐹𝑇(𝑥) = ∑ 𝑓𝑡(𝑥)
𝑇
𝑡=1  where each 𝑓𝑡 is a weak learner with 𝑥 as input. Each 
weak learner produces an output hypothesis, h(xi), for each sample in the training set. At each 
iteration t, a weak learner is selected and assigned a coefficient 𝛼𝑡 such that the sum training error 
Et of the resulting t-stage boost classifier is minimized. 
A multilayer perceptron (MLP) is a feedforward artificial neural network (ANN) which consists 
of an input layer, an output layer and one or more hidden layers and utilizes backpropagation for 
training the data. The MLP commonly uses a nonlinear activation function which maps the 
weighted inputs to the output of each neurons in the hidden layers. In an MLP, the connection 
weights are changed based on the error between the generated output and expected result. Two of 
the most common activation functions are the rectified linear unit (ReLU), 𝑓(𝑥) = 𝑥+ and the 
hyperbolic tangent, 𝑦(𝑥𝑖) = tanh (𝑥𝑖). 
 
4 Results  
4.3 Summary Statistics 
               For the purpose of variable selection in our classification model, we start out by 
investigating correlations among 30 continuous predictor variables. Correlation is found to be high 
(0.77) between serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as 
given from Fig 3. However, AST is a major risk factor in the prediction of CHD, as has been 
reported in the literature (Shen et. al, 2015). Jianying (2015) finds AST levels to be significantly 
higher in CHD patients than in the control group and hence can be used as biochemical markers to 
predict the severity of CHD. A high correlation of 0.89 was determined between body-mass-index 
and weight which seemed normal whereas correlation between hemoglobin and red blood cells 
was 0.74. While the association of hemoglobin with clinically recognized CHD is limited in 
research (Chonchol, 2008), the role of red blood cells in CHD is well researched in the literature 
(Madjid, 2013). It has been investigated that high blood glucose levels for non-diabetic patients 
can significantly increase the risk for development of CHD (Neilson, 2006) which is depicted in 
Fig. 3 by a high correlation value of 0.79 between glycohemoglobin and glucose. Further, we find 
a correlation of 0.46 between protein and albumin. Lower levels of serum albumin have been 
reported to be linked with increased levels of cardiovascular mortality as well as CHD (Shaper, 
2004) while higher level of protein is reported to increase risks of CHD (Clifton, 2011). Serum 
Lactate dehydrogenase (LDH) is found to be correlated with AST (correlation coefficient of 0.41), 
consistent with previous studies which suggest that increased value of LDH in active population 
is associated with low risk of CHD (Kopel et. al., 2012). Due to the importance of the risk factors 
(as reported in existing literature) of some of the correlated variables and their association with  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Correlation table for the independent predictor variables. In this table, moderately strong correlations 
among few pairs are observed (Glucose and Glycohemoglobin, Red blood cells and Hemoglobin, ALT and 
AST, Weight and Body-Mass-Index).  Rest of the pairs show fairly low correlation values, implying the 
variables after the LASSO-Majority voting stage are sufficiently decorrelated.   
 
CHD, LASSO regression was performed to correctly determine the predictor variables for further 
analysis.  
 
4.2 Model results 
          To identify variables that contribute to the variation in data, we apply LASSO to 100 
instances of randomly sampled datasets, with each containing 1300 examples of class CHD 
(negative class) and 1300 of class no-CHD (positive class).  We set 𝛼 in eq. (2) as 6 and find that 
ALT, glucose, hemoglobin, body mass index fails to contribute significantly in the data 
irrespective of strong experimental evidence in state-of-the-arts that favor those factors. From 
majority voting, some of the strong correlates are age, white blood cells, platelet count, red cell 
distribution width, cholesterol, LDH, uric acid, triglycerides, HDL, glycohemoglobin, gender, 
presence of diabetes, blood related stroke, moderate and vigorous work.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Model accuracy as a function of majority voting threshold. The threshold value of majority voting 
affects the classification accuracy of CHD as the selection of this value controls the number of variables 
that are to be channeled to our CNN model. The smaller is the threshold value, the larger is the set of 
variables. Based on the training loss, training accuracy and test accuracy, the threshold value between 16.67 
(100/6) – 20 (100/5) combining 100 instances of LASSO appears suitable for obtaining balanced per class 
(CHD and Non-CHD) classification accuracy.    
 To achieve the optimal number of features for training our CNN architecture, the threshold of the 
feature voting was kept in the range of 2 to 8. The highest accuracy obtained from training the 
network is 83.17% with a training loss of 0.489 with a threshold feature of 6 as shown in Fig. 4. 
The corresponding highest test accuracy obtained is 82.32%. LASSO regularization reduces the 
coefficients of three of the continuous predictor variables (Body-mass-index, glucose and ALT) 
and one categorical variable to zero which is determined to be highly correlated as seen in section 
4.1. With a threshold value of 6, the CNN architecture is trained separately on different sets of 
subsampled data sets. Subsampling is performed in varying ratios starting with the range 
1300:13000 (CHD: Non-CHD) and increased to 1300:4000 as shown in Table II.  
 
Table II: Training schedule for increasing class weight ratio and sampling for optimal threshold. A 
maximum training accuracy if 83.51% and minimum training loss of 0.489 is achieved with a 
misclassification penalty of 3:1 (CHD: Non-CHD) and a sampling ratio of 1300:4000 (CHD: Non-CHD). 
The corresponding test accuracy is reported as 82.32%. 
 
In each subsampled set, all CHD subjects are taken into consideration and the Non-CHD subjects 
are randomly chosen without replacement. For training purposes, the neural network is trained by 
varying the misclassification penalty from 10:1 (CHD: Non-CHD) to 3:1 as shown in Table II. 
The maximum accuracy of 83.51% and minimum training loss of 0.489 is obtained while training 
with a sampling ratio of 1300:4000 (CHD: Non-CHD) and misclassification penalty of 3:1(CHD:  
Non-CHD). The trained network is tested on a cohort of 31,779 (85.70% of the whole dataset) 
remaining samples and a test accuracy of 82.32% is obtained subsequently as reported in table II. 
The optimal sampling ratio (1300:4000) of class 1 to class 0 is maintained for the final training of 
the network as illustrated in Table III.  
Class Weight Sampling TPR TNR Train Accuracy (%) Test Accuracy (%) Training Loss 
10:1 
8:1 
6:1 
5:1 
3:1 
1300:13000 
1300:10000 
1300:8000 
1300:6000 
1300:4000 
0.690 
0.706 
0.741 
0.735 
0.778 
0.812 
0.827 
0.799 
0.80 
0.823 
78.00 
77.28 
80.00 
80.48 
83.51 
81.09 
82.67 
79.90 
79.96 
82.32 
0.684 
0.676 
0.595 
0.548 
0.489 
 Table III reports the final training of the CNN architecture with varying class (CHD: Non-CHD) 
weights to check for consistency of our results. With decrease in class weights, the training 
accuracy increases from 59.43% to 83.17% when the difference between the training and test 
accuracies becomes a minimum, indicating a reasonable generalization error as shown in Fig. 5. 
During training the number of epochs, the number of neurons in each dense layer except the last 
one, and the number of filters in each convolution layer are varied to obtain the best fit of the 
model. We have fine-tuned several hyperparameters that are associated with our model to obtain 
consistent class-wise accuracy. The optimization is performed using Adam as the activation 
function with a learning rate 0.006 and 60 epochs, and no scheduling of learning rate is used during 
the training. The best test accuracy obtained is 82.32% where the penalty of misclassification of 
class 1 is set three times higher than that of class 0.  
 
Table III: Training schedule for increasing class weight ratio and optimal sampling ratio attained from table 
I. The difference between the training (83.17%) and test (82.32%) accuracies attain the minimum when the 
misclassification penalty of class 1 is set three times higher than class 0.  
 
 
 
 
Class Weight TPR TNR Train Accuracy (%) Test Accuracy (%) Training Loss 
50:1 
25:1 
12:1 
8:1 
6:1 
4:1 
3:1 
0.980 
0.923 
0.860 
0.836 
0.817 
0.788 
0.773 
0.383 
0.568 
0.664 
0.686 
0.740 
0.770 
0.818 
59.43 
67.06 
71.98 
75.08 
80.13 
81.00 
83.17 
44.48 
58.04 
66.60 
69.76 
74.12 
77.10 
82.32 
1.591 
1.236 
0.965 
0.765 
0.620 
0.550 
0.489 
  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Training and test accuracies with varying misclassification penalties for class 1 and 0. The minimum 
difference between training and test accuracies is obtained with a class weight of 3:1 (CHD: Non-CHD) 
and a training loss = 0.489. The model is trained with an constant optimized learning rate of 0.006 and 60 
epochs. 
 
The performance of the proposed CNN classifier can be evaluated from the confusion matrix in 
Table IV. We specify the classification parameters as follows:  
TP: true positive classification cases (true predictions for class 1, i.e., true CHD predictions),  
TN: true negative classification cases (true predictions for class 0, i.e., true non- CHD predictions),  
FN: false negative classification cases (false predictions for class 1, i.e., false CHD predictions),  
FP: false positive classification cases (false predictions for class 0, i.e., false non- CHD 
predictions).  
Some commonly applied performance rates calculated are the true positive rate (TPR), the 
accuracy of predicting CHD (class 1) and the true negative rate (TNR), the accuracy of predicting 
non-CHD (class 0). The detailed values of TPR, TNR, train accuracy, test accuracy and training 
loss for all class weights are given in Table III. 
 
 
 
Table IV: Confusion matrix for the CNN classifier for coronary heart disease. Out of 208 coronary heart 
disease cases in the sample cohort, 161 cases were predicted correctly by the classifier. The proposed 
classifier also correctly predicts 25,828 cases where patient did not report coronary heart disease.  
 
 
In the present study, it is our objective for our classifier to predict the presence of CHD with higher 
(improved) accuracy than in previous studies. The recall rate (sensitivity) for correctly predicting 
the true positive rate for class 1 (presence of CHD) is 77% while the class 0 (absence of CHD) is 
81%. The CNN classifier has been tested on 31,779 subjects while maintaining almost the same 
TPR and TNR, contrary to previous reported studies which have considered significantly smaller 
samples.  
Partitioning a highly imbalanced dataset poses a lot of challenges and incurs unavoidable biases 
on a classifier’s performance. While, it is advised to keep same ratio of class-specific data in 
training and testing in state of the arts, however, in a highly imbalanced dataset it is often very 
challenging to get a high class 1 (true CHD prediction rate) accuracy as the testing data size 
increases.  The present method confirms that our proposed CNN architecture has the classification 
power of 77% to correctly classify the presence of CHD cases on a testing data, which is 85.70% 
of the total dataset. This result signifies that the proposed architecture can be generalized to other 
studies in healthcare with a similar order of features and imbalances.    
The performance of our binary classifier is calculated by computing the ROC curve (Yang et. al; 
2017). The area under the curve (AUC) value in the ROC curve is the probability that our proposed 
CNN classifier ranks a randomly chosen positive case (CHD) higher than a randomly chosen 
negative case (Non-CHD) (Tom 2005). Thus, the ROC curve behaves as a tool to select the 
possible optimal models and to reject the suboptimal ones, independently from the class 
distribution. It does so by plotting parametrically the true positive rate (TPR) vs the false positive 
rate (FPR) at various threshold settings as shown in Fig. 4. (Right). The calculated AUC is 0.767 
or 76.7% which is comparable to previous studies related to CHD (Martinez, Schwarcz, Valdez & 
Diaz, 2018). In highly imbalanced data sets balanced accuracy is often considered to be a more 
accurate metric than normal accuracy itself. The balanced accuracy of the model is determined to 
be (TPR + TNR)/2 = 0.795 or 79.5%. The fall out rate or the Type-I error of the model is 
5743/31571 = 18.2% and the miss rate or the Type-II error of the model is 47/210 = 22.6%. The 
positive likelihood ratio of the predicted model is 4.27 indicating that there is almost a 30% 
increase in probability post diagnosis in prediction of the presence of CHD in patients. A negative 
likelihood ratio of 0.27 was calculated which signifies that there is approximately 30% decrease 
in probability post diagnosis in prediction of absence of CHD in patients. 
 
4.3. Comparison of ML models 
          Machine learning models discussed in section 3.2 are implemented and tested on our test 
cohort. The prediction results from these methods are then compared with the results of our 
proposed CNN architecture. All models are implemented with optimized parameters and then 
compared based on the true positive rate (recall) and true negative rate (sensitivity). Corresponding 
test accuracies and AUC values are also determined. Logistic regression and adaboost 
classification result in highest test accuracies but these classifiers suffer from low recall values 
which is the true positive rate for coronary heart disease detection. While the recall values obtained 
from SVM and random forest are comparable to that of our proposed CNN model, our model 
predicts the negative (Non-CHD) cases with higher accuracy as shown in Table V. The balanced 
accuracy of our model (79.5%) is also higher than individual accuracies from that of SVM or 
random forest classifiers. An optimized two-layer multilayer perceptron resulted in a low recall 
value of 66.34% when tested on our test cohort. Results in Table V show that SVM and random 
forest classifiers perform better than logistic, adaboost and MLP classifiers, but the specificity and 
test accuracy are significantly lower as compared to our designed CNN classifier. The CNN 
classifier results in high specificity and test accuracy along with high values of recall and AUC. 
 
Table V: Comparison of machine learning models for coronary heart disease prediction. As compared to 
traditional machine learning models, our proposed model attains a recall value of 0.77 which is comparable 
to the SVM classifier. However, specificity (0.81) and test accuracy (0.82) of our model are significantly 
higher than the SVM classifier.  
 Recall (%) Specificity (%) Test Accuracy (%) AUC 
Logistic Regression 51.44 91.15 90.89 71.29 
SVM 77.40 77.87 77.87 77.64 
Random Forest 76.44 76.06 76.06 76.25 
AdaBoost 52.88 90.36 90.12 71.63 
MLP 66.34 78.88 78.80 72.61 
Our model 77.3 81.8 82.32 76.78 
 
These results confirm that the CNN classifier outperforms all existing commonly used machine 
learning models for coronary heart disease prediction in terms of accuracy in prediction for both 
CHD and Non-CHD classes. 
 
5. Discussion, Conclusion and Perspectives 
             In this paper, we propose a multi-stage model to predict CHD using a highly imbalanced 
clinical data containing both qualitative and quantitative attributes. For such clinical data, 
imbalance is an unavoidable characteristic due to the nature of the availability of data. However, 
the data imbalance adversely affects the performance of any state-of-the-art classifier and, as a 
remedy of this problem, conventional techniques, such as data augmentation strategy, may be 
biologically implausible for several attributes in the data. By way of extensive experimentation 
and validation above, we establish that a special-purpose, shallow convolutional neural network 
exhibits a considerable degree of resilience towards data imbalance, thereby producing 
classification accuracy superior to the state-of-the-art machine learning models (Table 5). Our 
model is simple in concept, modular in design, resilient to data imbalance, and far-reaching in 
significance.      
The model begins with the application of LASSO regression in order to identify the contribution 
of variables or attributes in the data variation. Using multiple instances of randomly subsampled 
datasets, LASSO is performed several times to check the consistency of the contribution, a crucial 
step of our algorithm to control the true-negatives of variable selection. Finally, a majority voting 
algorithm is applied to extract the variables of interest, a step that achieves dimensionality 
reduction by excising unimportant variables. We do not perform any conventional dimension 
reduction techniques, such as Local Linear Embedding, Principal Component Analysis and t-
Stochastic Neighborhood Embedding, because these methods generally provide dimensions that 
are linear or nonlinear combination of the data variables, thus the methods are deficit in terms of 
interpretation of the derived dimensions. For example, a dimension as a linear combination of body 
mass index and alkaline phosphatase (ALP) is difficult to interpret. Now, whether or not, LASSO 
reflects the true importance of a variable through its shrinkage, and if it does not, then constructing 
an appropriate optimization function require further testing and would be a potential research 
avenue.   
Once we obtain the contributory variables, we channel them to our 1D feedforward convolutional 
neural network. It is worth to mention that our work is not intended to provide a sophisticated 
architecture of a neural network. Instead, our goals are to establish the claim that one can apply 
convolutional stages despite the scarcity of data and the absence of well-defined data augmentation 
techniques; to show that the shallow layers of convolution indeed offer resilience to data imbalance 
(Table IV) problem by dint of a training schedule (section 3.2.1). We establish the claims in terms 
of our results in Table V, where, in contrast to Logistic Regression and Adaboost, our model 
provides a balanced classwise classification accuracy.  In a cohort of 37,079 individuals with high 
imbalance between presence of CHD and Non-CHD, we show that it is possible to predict the 
CHD cases with 77.3% and Non-CHD cases with 81.8% accuracy, which indicates that the CHD 
class, which is deficit in the number of samples, does not suffer significantly from the data 
imbalance.   
The preprocessing stage, consisting of repeated LASSO and majority voting, is pivotal in filtering 
out highly correlated variables, setting green flags only for the decorrelated ones to be channeled 
to our CNN model. This is clearly observed from Figure 3. Each LASSO stage maintains 1:1 ratio 
of CHD:Non-CHD data to avoid the adverse effect of data imbalance on the final shrinkage 
parameters 𝛾. However, 1:1 ratio does not encapsulate enough variation of the Non-CHD as this 
class contains large number of data. We repeat LASSO with different randomly sampled subsets 
and eventually apply majority voting to assess the importance of a variable. Once the 
important/contributory variables are identified, we discard their LASSO values in this paper. In 
future work, instead of disregarding the LASSO values, we can integrate them to the subsequent 
CNN model as priors, a step that is expected to enhance the performance of the model.    
A possible future extension of this work can be the implementation of CNN for predictions from 
similar clinical datasets with such imbalanced number of positive and negative classifications 
exist. As explained before, our model can also be used as a transfer learning model and the last 
two dense layers can be retrained with the new data. We will also focus on the characterization of 
the training data so that a sophisticated sampling technique can be designed instead of uniform 
sampling of input data. It would be interesting to test if the extension of shallow CNN models, in 
terms of architecture and data sampling, to implement neural net based learning on similar clinical 
data sets improves the prediction accuracy of the classification process.   
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